24:I[7748,["268","static/chunks/aaea2bcf-705c747c36d33c22.js","839","static/chunks/839-631463a41726f237.js","320","static/chunks/320-fa817057570f2b68.js","551","static/chunks/app/article/%5Bid%5D/page-b53fad440e632bf3.js"],"default"] 25:I[6437,["268","static/chunks/aaea2bcf-705c747c36d33c22.js","839","static/chunks/839-631463a41726f237.js","320","static/chunks/320-fa817057570f2b68.js","551","static/chunks/app/article/%5Bid%5D/page-b53fad440e632bf3.js"],"default"] 27:I[5504,["268","static/chunks/aaea2bcf-705c747c36d33c22.js","839","static/chunks/839-631463a41726f237.js","320","static/chunks/320-fa817057570f2b68.js","551","static/chunks/app/article/%5Bid%5D/page-b53fad440e632bf3.js"],"default"] 26:T540,

LONDON, April 5, 2024 /PRNewswire/ --

Teleios Capital Partners LLC, a long-standing shareholder in Marel, has today issued the below statement.

Attributed to Adam Epstein, Co-Founder of Teleios Capital Partners:

"As a long-term shareholder for over five years, we wrote to Marel last November to convey our support for rebuffing JBT's initial approach, which we felt sought to capitalise on Marel's governance shortcomings. We welcome JBT's decision to revise its position, through both an improved valuation and more compelling deal structure, which we believe is to the benefit of all shareholders, including those who wish to participate in the combined company's upside. We support their current proposal."

For media enquiries, please contact Greenbrook:

teleioscapital@greenbrookadvisory.com, +44 207 952 2000

View original content:https://www.prnewswire.co.uk/news-releases/teleios-capital-partners-statement-from-significant-marel-shareholder-on-jbt-transaction-agreement-302109239.html

Tags

More Like This

Teleios Capital Partners: Letter to the Board of Directors of Marel

Teleios Capital Partners Announces Promotion of Max Steinebach to Partner, Reflecting Firm's Continued Growth

Claure Group Acquires Significant Stake in eB Capital, One of the Leading Alternative Investment Firms in Brazil

Statement from Gatemore Capital Management LLP on Elementis plc

Sparta Capital Sends Letter to Board of Directors of Wood Group

Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million

TIS Has Signed Binding Agreement With Marlin Equity Partners to Secure a Majority Growth Investment

EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics